PRME logo

Prime Medicine (PRME)

Profile

Full Name

Prime Medicine, Inc.

Ticker Symbol

PRME

Exchange

NASDAQ

Sector

Healthcare

Industry

Biotechnology

Country

United States

IPO

October 20, 2022

Indexes

Not included

Website

http://primemedicine.com

Employees

214

Key Details

Price

$1.66

Market Cap

-

Last Dividend

-

TTM Dividend Yield

-

Annual Revenue

$2.98M(+100.00% YoY)

Annual EPS

-

PE Ratio

-

Next earnings date

N/A

Next ex-dividend date

N/A

Next split date

N/A

Price

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Current Price

$1.66
PRME price is $1.66

Price All-time High

$21.72
PRME price is currently -92.36% below its historical high of $21.72

Price Most Recent Change

-6.68%
PRME price was down -6.68% on Apr 3, 2025

Price YTD Change

-45.57%
PRME price is down -45.57% since January 1st

Price 1-year Change

-71.96%
PRME price is down -71.96% year-on-year

Price 3-year Change

-91.79%
PRME price is down -91.79% over the past 3 years

Capitalization

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Market cap

Market Cap

-
PRME market capitalization value is unknown

Market Cap 3-year Change

-
PRME market capitalization 3-year change is unknown

Market Cap All-time High

-
PRME market capitalization all-time high is unknown

Market Cap Sector Rank

-
PRME market capitalization is unknown

Shares Outstanding

Shares Outstanding 1-Year Change

-
PRME shares outstanding 1-year change is unknown

Shares Outstanding 3-Year Change

-
PRME shares outstanding 3-year change is unknown

Technical Indicators

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Beta

2.53
PRME beta is 2.53

200-day SMA

$3.66
PRME price is currently -54.63% below its 200-day simple moving average

50-day SMA

$2.38
PRME price is currently -30.29% below its 50-day simple moving average

RSI

31.41
PRME 14-day relative strength index is 31.41

Volume

1.00
PRME 30-day relative volume is 1.00

ATR

$0.20
PRME average true range is $0.20

10-day Historical Volatility

77.04%
PRME 10-day historical volatility is 77.04%

Dividend

Income Statement

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Revenue

Revenue

$2.98M
PRME annual revenue is $2.98 million

Revenue Analysts Estimate

$19.69M
PRME annual revenue is currently -84.85% lower than the consensus analysts' forecast

Revenue 1-year Change

+100%
PRME annual revenue is up +100% year-on-year

Revenue Sector Rank

21.12%
PRME annual revenue is higher than 21.12% of companies in Healthcare sector

EPS

EPS

-
PRME annual earnings per share value is unknown

EPS Analysts Estimate

-$1.16
PRME annual earnings per share is currently equal to the consensus analysts' forecast

EPS 1-year Change

-
PRME annual earnings per share 1-year change is unknown

EPS Sector Rank

-
PRME annual earnings per share is unknown

Profit

Gross Profit

-
PRME annual gross profit value is unknown

Gross Margin

-
PRME annual gross profit margin value is unknown

Operating Profit

-$202.47M
PRME annual operating income is -$202.47 million

Operating Margin

-
PRME annual operating profit margin value is unknown

Net Income

-$195.88M
PRME annual net profit is -$195.88 million

Net Margin

-
PRME annual net profit margin value is unknown

Expenses

Total Expenses

$205.45M
PRME annual total expenses is $205.45 million

Operating Expenses

$205.45M
PRME annual total operating expenses is $205.45 million

Cost Of Goods Sold

-
PRME annual cost of goods sold value is unknown

Selling, General & Administrative Expenses

$50.16M
PRME annual SGA is $50.16 million

Depreciation And Amortization

$6.13M
PRME annual depreciation & amortization is $6.13 million

Interest Expense

-
PRME annual interest expense value is unknown

Income Tax

$0.00
PRME annual income tax is $0.00

EBIT & EBITDA

EBIT

-$202.47M
PRME annual earnings before interest & taxes is -$202.47 million

EBITDA

-$195.85M
PRME annual EBITDA is -$195.85 million

Balance Sheet

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Assets

Total Assets

$297.51M
PRME annual total assets is $297.51 million

Non Current Assets

$85.62M
PRME annual long term assets is $85.62 million

Current Assets

$211.89M
PRME annual total current assets is $211.89 million

Cash And Cash Equivalents

$182.48M
PRME annual cash & cash equivalents is $182.48 million

Accounts Receivable

-
PRME annual accounts receivable value is unknown

Inventory

-
PRME annual inventory value is unknown

Liabilities

Total Liabilities

$144.36M
PRME annual total liabilities is $144.36 million

Long Term Liabilities

$106.40M
PRME annual total long term liabilities is $106.40 million

Current Liabilities

$37.96M
PRME annual total current liabilities is $37.96 million

Accounts Payable

$11.35M
PRME annual accounts payable is $11.35 million

Debt

Total Debt

$40.79M
PRME annual total debt is $40.79 million

Total Debt 1-year Change

+199.23%
PRME annual total debt is up +199.23% year-on-year

Long Term Debt

$37.18M
PRME annual long term debt is $37.18 million

Short Term Debt

-
PRME annual short term debt value is unknown

Equity & Capital

Shareholders Equity

$153.15M
PRME annual stockholders equity is $153.15 million

Book Value

$153.15M
PRME annual book value is $153.15 million

Retained Earnings

-$687.21M
PRME annual retained earnings is -$687.21 million

Working Capital

$173.93M
PRME annual working capital is $173.93 million

Cash Flow Statement

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Cashflow Activities

Cash From Operations

-$122.86M
PRME annual cash flow from operations is -$122.86 million

Cash From Operations 1-year Change

+25.72%
PRME annual cash flow from operations is up +25.72% year-on-year

Cash From Investing

$68.46M
PRME annual cash flow from investing activities is $68.46 million

Cash From Investing 1-year Change

+265.86%
PRME annual cash flow from investing activities is up +265.86% year-on-year

Cash From Financing

$195.88M
PRME annual cash flow from financing activities is $195.88 million

Cash From Financing 1-year Change

+29804.73%
PRME annual cash flow from financing activities is up +29804.73% year-on-year

CAPEX

CAPEX

$7.29M
PRME annual capital expenditures is $7.29 million

CAPEX 1-year Change

-16.39%
PRME annual capital expenditures is down -16.39% year-on-year

Free Cash Flow

Free Cash Flow

-$130.16M
PRME annual free cash flow is -$130.16 million

Free Cash Flow 1-year Change

+25.25%
PRME annual free cash flow is up +25.25% year-on-year

Profitability Ratios

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Margins

Gross Margin

-
PRME annual gross profit margin value is unknown

Operating Margin

-
PRME annual operating profit margin value is unknown

Net Margin

-
PRME annual net profit margin value is unknown

ROA & ROE

ROA

-65.84%
PRME annual return on assets is -65.84%

ROE

-127.90%
PRME annual return on equity is -127.90%

Valuation

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

PE Ratio

PE Ratio

-
PRME price to earnings ratio value is unknown

PE Ratio Sector Rank

-
PRME price to earnings ratio is unknown

PB Ratio

PB Ratio

-
PRME price to book ratio value is unknown

PB Ratio Sector Rank

-
PRME price to book ratio is unknown

PS Ratio

PS Ratio

-
PRME price to sales ratio value is unknown

PS Ratio Sector Rank

-
PRME price to sales ratio is unknown

Enterprise value

Enterprise Value

-
PRME enterprise value value is unknown

Enterprise Value Sector Rank

-
PRME enterprise value is unknown

EV/EBITDA

EV/EBITDA

-
PRME EV/EBITDA value is unknown

EV/EBITDA Sector Rank

-
PRME EV/EBITDA is unknown

Financial Health

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Liquidity

Current Ratio

5.58
PRME annual current ratio is 5.58

Quick Ratio

-
PRME annual quick ratio value is unknown

Leverage

Debt To Equity

0.27
PRME annual debt to equity ratio is 0.27

Interest Coverage Ratio

-
PRME annual interest coverage ratio value is unknown

Risk & Stability

Piotroski F-Score

-
PRME piotroski f-score value is unknown

Altman Z-Score

-
PRME altman z-score value is unknown

Analyst ratings

Recent major analysts updates

Mar 20, 25 Chardan Capital
Buy
Mar 19, 25 HC Wainwright & Co.
Buy
Mar 4, 25 Citizens Capital Markets
Market Outperform
Mar 3, 25 HC Wainwright & Co.
Buy
Mar 3, 25 Chardan Capital
Buy
Dec 10, 24 JMP Securities
Market Outperform
Dec 3, 24 Guggenheim
Buy
Oct 25, 24 HC Wainwright & Co.
Buy
Aug 9, 24 HC Wainwright & Co.
Buy
May 20, 24 HC Wainwright & Co.
Buy

Institutional Ownership

Similar stocks

  • What is the ticker symbol for Prime Medicine?
  • Does Prime Medicine pay dividends?
  • What sector is Prime Medicine in?
  • What industry is Prime Medicine in?
  • What country is Prime Medicine based in?
  • When did Prime Medicine go public?
  • Is Prime Medicine in the S&P 500?
  • Is Prime Medicine in the NASDAQ 100?
  • Is Prime Medicine in the Dow Jones?
  • When does Prime Medicine report earnings?
  • Should I buy Prime Medicine stock now?

What is the ticker symbol for Prime Medicine?

The ticker symbol for Prime Medicine is NASDAQ:PRME

Does Prime Medicine pay dividends?

No, Prime Medicine does not pay dividends

What sector is Prime Medicine in?

Prime Medicine is in the Healthcare sector

What industry is Prime Medicine in?

Prime Medicine is in the Biotechnology industry

What country is Prime Medicine based in?

Prime Medicine is headquartered in United States

When did Prime Medicine go public?

Prime Medicine's initial public offering (IPO) was on October 20, 2022

Is Prime Medicine in the S&P 500?

No, Prime Medicine is not included in the S&P 500 index

Is Prime Medicine in the NASDAQ 100?

No, Prime Medicine is not included in the NASDAQ 100 index

Is Prime Medicine in the Dow Jones?

No, Prime Medicine is not included in the Dow Jones index

When does Prime Medicine report earnings?

The date for Prime Medicine's next earnings report has not been announced yet

Should I buy Prime Medicine stock now?

As of today, analysts generally recommend a 'Strong buy' rating. However, it's important to do your own research and consider your financial situation before making any investment decisions
On this page